Taiwan Post-Stroke Disability Study

NCT06772194 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2025-05-13

No results posted yet for this study

Summary

Stroke remains a major health issue in Taiwan, being the fourth leading cause of death and the top cause of disability. While past research has focused on functional outcomes at three months post-stroke, stroke can cause a range of disabilities in areas such as motor function, swallowing, cognition, depression, and epilepsy.

This study will investigate these disabilities by enrolling 2,000 acute stroke patients (both ischemic and hemorrhagic) from 10 medical centers across Taiwan. Data will be collected at three key points: at enrollment, three months, and twelve months post-stroke, using surveys, assessments, imaging, and blood samples. The aim is to examine the prevalence, risk factors, and long-term changes of post-stroke disabilities, ultimately seeking ways to reduce the health burden of stroke in Taiwan.

Conditions

Sponsors & Collaborators

  • National Taiwan University Hospital Hsin-Chu Branch

    collaborator OTHER
  • National Taiwan University Hospital, Yun-Lin Branch

    collaborator OTHER
  • Shin Kong Wu Ho-Su Memorial Hospital

    collaborator OTHER
  • Mackay Memorial Hospital

    collaborator OTHER
  • Chang Gung Memorial Hospital

    collaborator OTHER
  • National Cheng Kung University

    collaborator OTHER
  • Landseed Hospital

    collaborator OTHER
  • Taichung Veterans General Hospital

    collaborator OTHER
  • Taipei Veterans General Hospital, Taiwan

    collaborator OTHER_GOV
  • Tri-Service General Hospital

    collaborator OTHER
  • AbbVie

    collaborator INDUSTRY
  • Taipei Medical University Shuang Ho Hospital

    collaborator OTHER
  • Chi Mei Medical Hospital

    collaborator OTHER
  • Chang Gung Memorial Hospital, Keelung

    collaborator UNKNOWN
  • National Taiwan University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-21
Primary Completion
2028-09-30
Completion
2028-09-30

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06772194 on ClinicalTrials.gov